US88025U1097 - TXG - A2PPQJ (XNAS)
10X GENOMICS INC Acción
14,71 USD
Cotizaciones actuales de 10X GENOMICS INC
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria | Variación diaria % |
---|---|---|---|---|---|---|
NASDAQ |
TXG
|
USD
|
23.12.2024 17:50
|
14,71 USD
| 14,04 USD | 4,77 % |
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
1,65 % | -0,41 % | 2,80 % | -35,14 % | -25,10 % | -74,00 % | -80,07 % |
Firmenprofil zu 10X GENOMICS INC Aktie
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Investierte Fonds
Folgende Fonds haben in investiert: 10X GENOMICS INC investiert:
Fonds | Vol. in Mio 26,43 | Anteil (%) 0,20 % |
Fonds | Vol. in Mio 632,22 | Anteil (%) 0,17 % |
Fonds | Vol. in Mio 61,33 | Anteil (%) 0,06 % |
Fonds | Vol. in Mio 1,60 | Anteil (%) 0,06 % |
Fonds | Vol. in Mio 929,27 | Anteil (%) 0,06 % |
Unternehmensdaten zur 10X GENOMICS INC Aktie
Name 10X GENOMICS INC
Firma 10x Genomics, Inc.
Symbol TXG
Website https://www.10xgenomics.com
Heimatbörse
NASDAQ
WKN A2PPQJ
ISIN US88025U1097
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Healthcare Information Services
CEO Dr. Serge Saxonov Ph.D.
Marktkapitalisierung 3 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 1,3 T
Adresse 6230 Stoneridge Mall Road, 94588-3260 Pleasanton
IPO Datum 2019-09-12
Aktien-Splits
Datum | Split |
---|---|
17.07.2006 | 1:2 |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | 1KJ.F |
NASDAQ | TXG |
Weitere Aktien
Investoren die 10X GENOMICS INC die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.